Cargando…
Outsourcing biopharma R & D to India /
The trend of outsourcing to India for research and development is catching on fast. Over the last decade, worldwide pharmaceutical and biotechnology companies have made India their choice for a research destination. Initially R & D was inclined more towards developing products for the Indian mar...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford ; New York :
Biohealthcare,
2011.
|
| Colección: | Woodhead Publishing series in biomedicine ;
no. 2. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn828743864 | ||
| 003 | OCoLC | ||
| 005 | 20231117044834.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 110826s2011 enk ob 001 0 eng d | ||
| 040 | |a E7B |b eng |e pn |c E7B |d OCLCO |d OCLCQ |d OPELS |d N$T |d OCLCF |d YDXCP |d EBLCP |d DEBSZ |d OCLCQ |d U3W |d D6H |d OCLCA |d ESU |d WYU |d C6I |d CASUM |d OCLCO |d OCLCQ |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 866858685 | ||
| 020 | |a 9781908818010 |q (electronic bk.) | ||
| 020 | |a 1908818018 |q (electronic bk.) | ||
| 020 | |z 9781907568084 |q (hbk.) | ||
| 020 | |z 1907568085 |q (hbk.) | ||
| 035 | |a (OCoLC)828743864 |z (OCoLC)866858685 | ||
| 043 | |a a-ii--- | ||
| 050 | 4 | |a HD9672.I52 |b C49 2011eb | |
| 060 | 0 | 0 | |a 2011 H-848 |
| 060 | 1 | 0 | |a QV 778 |
| 072 | 7 | |a BUS |x 070000 |2 bisacsh | |
| 082 | 0 | 4 | |a 338.476151 |2 22 |
| 100 | 1 | |a Chowdhury, Probir Roy. | |
| 245 | 1 | 0 | |a Outsourcing biopharma R & D to India / |c Probir Roy Chowdhury. |
| 260 | |a Oxford ; |a New York : |b Biohealthcare, |c 2011. | ||
| 300 | |a 1 online resource (xiv, 116 pages). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Woodhead Publishing series in biomedicine, |x 2050-0289 ; |v no. 2 | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a The trend of outsourcing to India for research and development is catching on fast. Over the last decade, worldwide pharmaceutical and biotechnology companies have made India their choice for a research destination. Initially R & D was inclined more towards developing products for the Indian market within the country. This led to several multinational companies opening up production plants in India, primarily due to the globalization of the Indian economy and offshoring jobs to India. Alongside, several global pharma-biotech majors ascertained large market requirements within the country and capitalized on the advantage of serving Indian customers. Strategies were devised to optimize operational expenses with the setting up of on-site R & D to develop products for local requirements. In view of this, this book seeks to explore various nuances of the outsourcing sector with respect to biopharma in India. Constitutes the first ever comprehensive insight on the Indian biopharma sectorProvides a perspective based on practical hands-on legal experienceSimply structured, clearly presented and free from excessive legal jargon. | ||
| 505 | 0 | |a Cover; Woodhead Publishing Seriesin Biomedicine; Outsourcing biopharma R & D to India; Copyright; Contents; Acknowledgements; About the author; 1 Biopharma outsourcing in India: its evolution; 1.1 What is outsourcing?; 1.2 What is R & D?; 1.3 Organisational patterns in R & D outsourcing; 1.4 R & D outsourcing in the pharmaceutical industry; 1.5 India as the emerging hub of R & D outsourcing in the pharmaceutical industry; 1.6 Outsourcing models prevalent in India: cooperation models for outsourced services; 1.7 Key issues involved in outsourcing; Notes. | |
| 505 | 8 | |a 2 India's core competitive advantage in R & D in the biopharma sector: the impetus for outsourcing2.1 Introduction; 2.2 Cost competitiveness; 2.3 Resources and skill; 2.4 The role of the government; 2.5 Conclusion; Notes; 3 Different modes of outsourcing biopharma R & D to India; 3.1 Indian companies involved in outsourcing activities; 3.2 Contract research services; 3.3 Contract manufacturing organisations; 3.4 Drug substance manufacturing; 3.5 Drug product manufacturing; 3.6 Process development; 3.7 Analytical methods and characterisation. | |
| 505 | 8 | |a 3.8 Business models for contract manufacturing organisations3.9 Insights into outsourcing of product development and manufacture; 3.10 Clinical trials; 3.11 Advantages and disadvantages of doing clinical trials in India; 3.12 Active pharmaceutical ingredient and technology transfer; 3.13 Conclusions and implications; Notes; 4 The Indian regulatory environment: a historical perspective; 4.1 Indian Council for Medical Research; 4.2 Central Drugs Standard Control Organisation; 4.3 Department of Biotechnology; 4.4 National Pharmaceutical Pricing Authority; 4.5 Overview of the industry; Notes. | |
| 505 | 8 | |a 5 Implications of the changing regulatory environment in India5.1 Introduction; 5.2 Capacity Building Programme: recent development5; 5.3 Clinical Trials Registry -- India; 5.4 The Indian Society for Clinical Research; 5.5 Conclusion; Notes; 6 Creating contracts for outsourcing in the biopharma industry; 6.1 Biopharma outsourcing; 6.2 Preliminary documentation; 6.3 Drafting of the biopharma outsourcing agreement; 6.4 Specific considerations in different types of agreements; 6.5 Conclusion; Notes; 7 Environmental, health and safety guidelines and biopharma outsourcing: an Indian perspective. | |
| 505 | 8 | |a 7.1 Introduction7.2 The environmental, health and safety guidelines; 7.3 EHS guidelines and India; 7.4 Challenges faced by Indian companies in EHS compliance; 7.5 Conclusion; Notes; 8 Certifications; 8.1 Introduction; 8.2 Certifications; 8.3 Manufacturing licence; 8.4 Good Manufacturing Practices; 8.5 No-Objection Certificate and Certificate of Origin; 8.6 Certificate of a Pharmaceutical Product; 8.7 Certifications for clinical trials; 8.8 International regulatory certifications; 8.9 Conclusion; Notes; 9 The need for due diligence of service providers; 9.1 Introduction. | |
| 650 | 0 | |a Pharmaceutical biotechnology industry |z India. | |
| 650 | 0 | |a Research |x Contracting out |z India. | |
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Biopharmaceutics. | |
| 650 | 0 | |a Research. | |
| 650 | 1 | 2 | |a Technology, Pharmaceutical |0 (DNLM)D013678 |
| 650 | 2 | 2 | |a Biopharmaceutics |0 (DNLM)D001702 |
| 650 | 2 | 2 | |a Research |0 (DNLM)D012106 |
| 650 | 6 | |a Biotechnologie pharmaceutique |0 (CaQQLa)201-0344927 |x Industrie |0 (CaQQLa)201-0344927 |z Inde. |0 (CaQQLa)201-0482676 | |
| 650 | 6 | |a Techniques pharmaceutiques. |0 (CaQQLa)201-0138380 | |
| 650 | 6 | |a Biopharmacie. |0 (CaQQLa)201-0050334 | |
| 650 | 6 | |a Recherche. |0 (CaQQLa)201-0029424 | |
| 650 | 7 | |a research (function) |2 aat |0 (CStmoGRI)aat300054687 | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x General. |2 bisacsh | |
| 650 | 7 | |a Research |2 fast |0 (OCoLC)fst01095153 | |
| 650 | 7 | |a Pharmaceutical technology |2 fast |0 (OCoLC)fst01060211 | |
| 650 | 7 | |a Biopharmaceutics |2 fast |0 (OCoLC)fst00832650 | |
| 650 | 7 | |a Pharmaceutical biotechnology industry |2 fast |0 (OCoLC)fst01060113 | |
| 650 | 7 | |a Research |x Contracting out |2 fast |0 (OCoLC)fst01095175 | |
| 651 | 7 | |a India |2 fast |0 (OCoLC)fst01210276 | |
| 655 | 4 | |a Internet Resources. | |
| 776 | 0 | 8 | |i Print version: |a Chowdhury, Probir Roy. |t Outsourcing biopharma R & D to India. |d Oxford ; New York : Biohealthcare, 2011 |w (DLC) 2011289196 |
| 830 | 0 | |a Woodhead Publishing series in biomedicine ; |v no. 2. |x 2050-0289 | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568084 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568084 |z Texto completo |